Table of Content

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Drivers
4.1.1 Growing Health Care Industry
4.1.2 Other Drivers
4.2 Restraints
4.2.1 Toxic Nature of Platinum Nanoparticles
4.2.2 Unfavorable Conditions in Non-medical End-user Industries Arising Due to COVID-19 Outbreak
4.3 Industry Value Chain Analysis
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Degree of Competition


5 MARKET SEGMENTATION
5.1 Product
5.1.1 Spherical
5.1.2 Cube
5.1.3 Square
5.1.4 Others
5.2 End-user Industry
5.2.1 Automotive
5.2.2 Health Care
5.2.3 Chemical
5.2.4 Others
5.3 Geography
5.3.1 Asia-Pacific
5.3.1.1 China
5.3.1.2 India
5.3.1.3 Japan
5.3.1.4 South Korea
5.3.1.5 Rest of Asia-Pacific
5.3.2 North America
5.3.2.1 United States
5.3.2.2 Canada
5.3.2.3 Mexico
5.3.3 Europe
5.3.3.1 Germany
5.3.3.2 United Kingdom
5.3.3.3 France
5.3.3.4 Italy
5.3.3.5 Rest of Europe
5.3.4 South America
5.3.4.1 Brazil
5.3.4.2 Argentina
5.3.4.3 Rest of South America
5.3.5 Middle-East and Africa
5.3.5.1 Saudi Arabia
5.3.5.2 South Africa
5.3.5.3 Rest of Middle-East and Africa


6 COMPETITIVE LANDSCAPE
6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
6.2 Market Share/Ranking Analysis**
6.3 Strategies Adopted by Leading Players
6.4 Company Profiles
6.4.1 American Elements
6.4.2 HiQ-Nano s.r.l.
6.4.3 Meliorum Technologies, Inc.
6.4.4 Metrohm India Limited
6.4.5 NanoBio Chemicals India Pvt. Ltd.
6.4.6 NANOCHEMAZONE
6.4.7 Nanocomposix
6.4.8 Nanoshel LLC
6.4.9 Nanostructured & Amorphous Materials, Inc.
6.4.10 Particular GMBH
6.4.11 PlasmaChem GmbH
6.4.12 Sigma-Aldrich
6.4.13 Strem Chemicals, Inc
6.4.14 TANAKA HOLDINGS Co., Ltd.
6.4.15 US Research Nanomaterials, Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS
7.1 Research and Development in Application of Patinum Nanoparticles in Nanobiomedicine
7.2 Other Opportunities